G. Kassiotis et al., A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice, EUR J IMMUN, 29(3), 1999, pp. 912-917
We have reported previously that in the central nervous system (CNS) local
expression of tumor necrosis factor (TNF) transgenes can trigger the develo
pment of oligodendrocyte apoptosis, primary inflammatory demyelination and
neurological dysfunction, accompanied by lymphocyte and macrophage infiltra
tion into the CNS. To distinguish between the local effects of transgene-en
coded TNF and the potential encephalitogenic effects of immune infiltrates
upon CNS disease pathogenesis, we have backcrossed Tg6074 TNF-transgenic mi
ce to mice deficient in CD4, beta 2-microglobulin (beta 2m), immunoglobulin
mu chain (Ig mu) or recombination activation gene-1 (Rag-1). TNF was capab
le of triggering undiminished primary demyelination in all of the immunodef
icient mice, in the presence of activated cells of the macrophage/microglia
l lineage. We conclude that TNF is sufficient to induce primary inflammator
y demyelination and neurological deficits even in the absence of adaptive i
mmunity.